SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899923-23-000072
Filing Date
2023-10-31
Accepted
2023-10-31 16:34:09
Documents
14
Period of Report
2023-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mygn-20231031.htm   iXBRL 8-K 31849
2 EX-10.1 myriad-firstamendmentex101.htm EX-10.1 92826
  Complete submission text file 0000899923-23-000072.txt   293028

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20231031.xsd EX-101.SCH 2140
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20231031_def.xml EX-101.DEF 14426
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20231031_lab.xml EX-101.LAB 27876
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20231031_pre.xml EX-101.PRE 15012
8 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20231031_htm.xml XML 2707
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 231365172
SIC: 2835 In Vitro & In Vivo Diagnostic Substances